Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by pabalooon May 11, 2020 8:57pm

85 Views

Post# 31014761

RE:RE:10 Bagger!!!

Lots of money being made here lately Swapper. Nice to see for a change. It's a stock that has a chance to really be a game changer for those who saw a great opportunity and took a chance. I'm thinking we could see 1.75 by the end of the month. Lots of new money coming in and few are selling below the ask. Now Ciphers head office can answer the phone again, I wouldn't have wanted to hear there answering machine last month

Bullboard Posts

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi